drugset / Trial / NCT06084156
A Study to Evaluate the DDI of HSK7653 With Metformin
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase 1, single center, open-label, single arm, drug-drug interaction study of HSK7653 and metformin in Healthy Subjects.
Timeline
- Start
- 2019-08-10
- Primary completion
- 2019-12-09
- Completion
- 2019-12-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HSK7653 | Unknown | 25 mg | — |
| Subject | Metformin | Small molecule | 1000 mg | — |